LAMP
The Boston-based company has developed a loop-mediated amplification assay and a novel lateral flow strip technology.
Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
Premium
The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.
KSL Pulse Scientific to Distribute Lucira Health Home COVID-19, Flu Molecular Test in Canada
The palm-sized single-use instrument uses shallow nasal swabs and nucleic acid amplification to identify COVID-19 and influenzas A and B.
Aptitude Medical Gets FDA EUA for Over-the-Counter COVID Saliva MDx
Aptitude's assay is the first OTC molecular COVID test authorized to use saliva as a sample type, according to the US Food and Drug Administration.
If commercialized, the assay will mark Lucira's entry into market for at-home diagnostics for sexually transmitted infections.
Mar 17, 2022
Feb 8, 2022
Lucira Health Enters Debt Facility of up to $80M
Feb 3, 2022
Jan 18, 2022
Canary Molecular POC SARS-CoV-2 Test Nabs CE Mark
Jan 13, 2022